Enlivex bets big on crypto prediction markets while advancing osteoarthritis therapy

Enlivex Therapeutics is blending biotech with blockchain. The clinical-stage company is deploying funds from its $212 million PE deal to build a crypto treasury

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Why traders are leaving BCH, XRP for BlockDAG’s 1,566% ROI potential: Only 24 hours left to buy BDAG at $0.003

Next Post

Sui price on edge as its mainnet goes through a network stall

Related Posts